GH1 and neoplasm: Anthropometric measures and GH responses to GHRHarg in 29 TGHD patients (n = 12 females) with effective pituitary radiotherapy dose are reported in Table 3; tumor diagnosis were medulloblastomas (n = 14), geminomas (n = 6), craniopharyngioma (n = 2), low grade gliomas (n = 3), PNET (n = 2), other (n = 2).